LOKELMA Trademark

Trademark Overview

On Monday, September 11, 2017, a trademark application was filed for LOKELMA with the United States Patent and Trademark Office. The USPTO has given the LOKELMA trademark a serial number of 87604023. The federal status of this trademark filing is REGISTERED as of Tuesday, April 16, 2019. This trademark is owned by ZS Pharma, Inc.. The LOKELMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hyperkalemia
lokelma

General Information

Serial Number87604023
Word MarkLOKELMA
Filing DateMonday, September 11, 2017
Status700 - REGISTERED
Status DateTuesday, April 16, 2019
Registration Number5728779
Registration DateTuesday, April 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hyperkalemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 15, 2017
Primary Code005
First Use Anywhere DateMonday, December 10, 2018
First Use In Commerce DateMonday, December 10, 2018

Trademark Owner History

Party NameZS Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94403
Party NameZS Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94403
Party NameZS Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94403

Trademark Events

Event DateEvent Description
Tuesday, March 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 14, 2017NEW APPLICATION ENTERED
Friday, September 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 14, 2017ASSIGNED TO EXAMINER
Friday, December 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, September 10, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 10, 2018SOU TEAS EXTENSION RECEIVED
Monday, September 10, 2018SOU EXTENSION 1 FILED
Monday, September 10, 2018SOU EXTENSION 1 GRANTED
Wednesday, September 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 29, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, January 29, 2019USE AMENDMENT FILED
Wednesday, February 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 13, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 14, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 16, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 2, 2024TEAS SECTION 8 & 15 RECEIVED

Related Keywords

lokelma hyperkalemia treatment preparations pharmaceutical